Clinical Trial

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Study acronym: ANCHOR
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
ANCHOR is a prospective, phase IV, interventional, single-arm, open-label study of 1,500 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare the asthma exacerbation rates before and after switching from albuterol or levalbuterol to albuterol plus budesonide inhalation aerosol as rescue therapy.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2027-03-31 -> 2027-02-03 2026-07-17
minor Completion moved earlier: 2027-03-31 -> 2027-02-03 2026-07-17
Trial Details
NCT Number NCT06422689
Lead Sponsor AstraZeneca
Collaborators: Premier HealthCare Solutions Inc.
Conditions Asthma
Enrollment 1,511 participants
Start Date 2024-05-10
Primary Completion 2027-02-03 (estimated)
Study Completion 2027-02-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-16